NCT07483788

Brief Summary

All Patients coming to the Operative Dentistry Department (DIDC-DUHS) with complain of pain in posterior teeth will be invited to participate. The treatment will be done by one dentist. Patient's medical and dental history will be recorded, and tooth will be checked for swelling, sensitivity, cavity type, and loosening of tooth. Special tests like the cold test, electric pulp test, and an X-ray will help assess the tooth's condition. Patient will also be asked to rate pain from 1-10. Before starting the treatment, the procedure will be explained to patient in detail, and written consent will be taken. The treatment will be done in two visits by one dentist. Patient will be given an injection to make tooth pain-free so that patient does not feel any discomfort during the treatment and the area will be kept clean using a rubber sheet. The dentist will remove the hole in tooth and remove the infected soft part of tooth and stop the bleeding. Then one of the two materials will be placed inside the tooth. A temporary filling will be placed first, and patient will come the next day for the final filling. An X-ray will be taken to check the result. If patient feel pain, may take ibuprofen (400 mg) as needed, and if the pain continues, please contact the dentist. Patient will be called for follow-ups after 1 day, 1 week, 1 month, and 3 months to make sure the tooth is healing properly.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Nov 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Nov 2024Jul 2026

Study Start

First participant enrolled

November 2, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

November 28, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 19, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

March 19, 2026

Status Verified

October 1, 2025

Enrollment Period

1.5 years

First QC Date

November 28, 2025

Last Update Submit

March 16, 2026

Conditions

Keywords

Symptomatic Irreversible PulpitisComplete pulpotomy

Outcome Measures

Primary Outcomes (1)

  • Short term outcome of complete pulpotomy using MTA vs Biodentine in Symptomatic Irreversible Pulpitis- A Randomized Controlled Trial

    Clinical outcome measure through Electric pulp testing (EPT) and radiographic outcome measure through Periapical index (PAI)

    3 months

Study Arms (2)

MTA

EXPERIMENTAL

Pulpotomy material MTA

Other: Biodentine pulpotomy

Biodentine

EXPERIMENTAL

Pulpotomy material Biodentine

Other: Biodentine pulpotomy

Interventions

Pulpotomy performed using Mineral Trioxide Aggregate (MTA)

BiodentineMTA

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Teeth of generally healthy patients having following criteria will be included:
  • Age between 18-40 years of both males and females
  • Carious exposed maxillary and mandibular molars teeth
  • Moderate to severe pain (VAS 4-10)
  • Diagnosed with Symptomatic irreversible pulpitis on cold test and Electric pulp test (EPT)
  • Periapical index of 1
  • Hemostasis is achieved within 10 mins after full pulpotomy

You may not qualify if:

  • Teeth of generally healthy patients having following criteria will be excluded:
  • Any traumatic injury
  • Non-restorable carious lesion
  • Immature or Open apices of roots
  • Internal or external Resorption
  • Calcified canals

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dr Khadija Zubair

Karachi, Sindh, Pakistan

RECRUITING

Dr Khadija Zubair

Karachi, Sindh, Pakistan

RECRUITING

Study Officials

  • Dr Khadija Zubair, Postgraduate Trainee- FCPS

    Dow University of Health Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dr Khadija Zubair, Postgraduate trainee- FCPS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postgraduate Trainee FCPS

Study Record Dates

First Submitted

November 28, 2025

First Posted

March 19, 2026

Study Start

November 2, 2024

Primary Completion

April 30, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

March 19, 2026

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

IPD will not be shared outside the study team to ensure patient confidentiality and privacy. Data will be used only for the purposes of this study and will remain restricted to the research team

Locations